[go: up one dir, main page]

DK0925070T3 - Antifungal kombinationsterapi - Google Patents

Antifungal kombinationsterapi

Info

Publication number
DK0925070T3
DK0925070T3 DK97941495T DK97941495T DK0925070T3 DK 0925070 T3 DK0925070 T3 DK 0925070T3 DK 97941495 T DK97941495 T DK 97941495T DK 97941495 T DK97941495 T DK 97941495T DK 0925070 T3 DK0925070 T3 DK 0925070T3
Authority
DK
Denmark
Prior art keywords
antifungal
inhibitors
combination therapy
combination
xmp
Prior art date
Application number
DK97941495T
Other languages
Danish (da)
English (en)
Inventor
Kenneth F Bartizal
George K Abruzzo
Amy M Flattery
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9620739.4A external-priority patent/GB9620739D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0925070T3 publication Critical patent/DK0925070T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97941495T 1996-09-12 1997-09-09 Antifungal kombinationsterapi DK0925070T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2632796P 1996-09-12 1996-09-12
GBGB9620739.4A GB9620739D0 (en) 1996-10-04 1996-10-04 Antifungal combination therapy
PCT/US1997/015987 WO1998010782A1 (fr) 1996-09-12 1997-09-09 Therapie antifongique combinee

Publications (1)

Publication Number Publication Date
DK0925070T3 true DK0925070T3 (da) 2003-12-01

Family

ID=26310166

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97941495T DK0925070T3 (da) 1996-09-12 1997-09-09 Antifungal kombinationsterapi

Country Status (21)

Country Link
EP (1) EP0925070B1 (fr)
JP (1) JP3288051B2 (fr)
KR (1) KR100380871B1 (fr)
CN (1) CN1235554A (fr)
AT (1) ATE248625T1 (fr)
AU (1) AU721334B2 (fr)
CA (1) CA2265824C (fr)
CY (1) CY2481B1 (fr)
CZ (1) CZ88499A3 (fr)
DE (1) DE69724626T2 (fr)
DK (1) DK0925070T3 (fr)
EA (1) EA002469B1 (fr)
EE (1) EE03748B1 (fr)
ES (1) ES2203819T3 (fr)
IL (1) IL128870A0 (fr)
NO (1) NO991207L (fr)
NZ (1) NZ334446A (fr)
PL (1) PL333282A1 (fr)
PT (1) PT925070E (fr)
SK (1) SK29999A3 (fr)
WO (1) WO1998010782A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK88496A3 (en) * 1994-11-08 1997-04-09 Glaxo Wellcome Sa Cyclic derivatives, manufacturing process thereof, pharmaceutical compositions containing them and their use antifungal sordaridin derivatives
US6069126A (en) * 1996-09-12 2000-05-30 Merck & Co., Inc. Antifungal combination therapy
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
KR100680464B1 (ko) * 2000-06-28 2007-02-08 주식회사 하이닉스반도체 반도체 소자의 캐패시터 제조 방법
JPWO2002098463A1 (ja) * 2001-06-05 2004-09-16 財団法人新産業創造研究機構 抗真菌組成物
NZ561675A (en) * 2005-04-07 2010-07-30 Toyama Chemical Co Ltd Pharmaceutical composition and method using antifungal agent in combination
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
PL2070536T3 (pl) 2006-10-06 2012-06-29 Toyama Chemical Co Ltd Kompozycja farmaceutyczna zawierająca pochodną fenyloamidyny oraz sposób stosowania kompozycji farmaceutycznej w kombinacji ze środkiem przeciwgrzybiczym
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
US20110076240A1 (en) * 2008-04-18 2011-03-31 Day Donal F Antifungal and Anti-Cariogenic Cellobio-Oligosaccharides Produced by Dextransucrase
CN102274215B (zh) * 2010-06-10 2013-04-10 吉林大学 一种具有与氟康唑协同抗真菌作用的增效剂
CN102274216B (zh) * 2010-06-10 2013-04-10 吉林大学 一种提高氟康唑抗真菌作用的增效剂
CN102274217B (zh) * 2010-06-10 2013-04-10 吉林大学 三氯生作为抗真菌药物氟康唑增效剂的新用途
JPWO2012060448A1 (ja) 2010-11-05 2014-05-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗真菌剤としての併用医薬組成物
JP2014518878A (ja) * 2011-05-24 2014-08-07 バイエル クロップサイエンス エルピー ポリエン系殺菌剤と非リボソーム型ペプチドの相乗的組み合わせ及び関連する使用方法
CN102319326A (zh) * 2011-07-23 2012-01-18 李玮 一种治疗脚癣的浸药卫生纸
CN114052029A (zh) * 2021-11-25 2022-02-18 兰州大学 具哌嗪和哌啶骨架的医用化合物在防治植物真菌病害中的用途
CN115721633B (zh) * 2022-03-25 2024-05-03 山东大学 羟基茜草素在作为t3ss小分子抑制剂中的应用
CN116473985B (zh) * 2023-03-29 2024-12-10 暨南大学 一种多烯类抗真菌药物组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds

Also Published As

Publication number Publication date
ATE248625T1 (de) 2003-09-15
EA002469B1 (ru) 2002-06-27
EE03748B1 (et) 2002-06-17
CA2265824A1 (fr) 1998-03-19
EA199900283A1 (ru) 1999-08-26
JP3288051B2 (ja) 2002-06-04
CN1235554A (zh) 1999-11-17
CY2481B1 (en) 2005-06-03
WO1998010782A1 (fr) 1998-03-19
SK29999A3 (en) 2000-02-14
PL333282A1 (en) 1999-11-22
EP0925070A1 (fr) 1999-06-30
JP2000503675A (ja) 2000-03-28
EP0925070B1 (fr) 2003-09-03
NZ334446A (en) 2000-11-24
CZ88499A3 (cs) 1999-10-13
CA2265824C (fr) 2004-11-09
NO991207L (no) 1999-05-11
AU721334B2 (en) 2000-06-29
DE69724626T2 (de) 2004-07-29
KR20000036054A (ko) 2000-06-26
ES2203819T3 (es) 2004-04-16
DE69724626D1 (de) 2003-10-09
AU4339297A (en) 1998-04-02
KR100380871B1 (ko) 2003-04-18
EE9900088A (et) 1999-10-15
PT925070E (pt) 2003-12-31
NO991207D0 (no) 1999-03-11
IL128870A0 (en) 2000-06-01

Similar Documents

Publication Publication Date Title
DK0925070T3 (da) Antifungal kombinationsterapi
WO2000072865A3 (fr) Utilisation combinee d'antifongiques
ATE365487T1 (de) Verbesserungen an und bezüglich verstellbaren stühlen und betten
BR9809951A (pt) Método para tratamento da obesidade
US6069126A (en) Antifungal combination therapy
Graybill Therapeutic agents
EP1157698A3 (fr) Traitement des maladies inflammatoires avec des nucleosides a base d'oxypurine
BR0211970A (pt) Uso de bibn4096 em combinação com outras drogas antienxaqueca para o tratamento de enxaqueca
Kamisato et al. Involvement of intracellular cyclic GMP and cyclic GMP-dependent protein kinase in α-elastin-induced macrophage chemotaxis
NO970178L (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
Shinohara et al. Successful use of boric acid to control azole-refractory Candida vaginitis in a woman with AIDS
IT1297538B1 (it) Enteroclisma di lattulosio/lattitolo con o senza aggiunta di neomicina per la cura della encefalopatia portosistemica acuta
HUP0000127A2 (hu) Több hatóanyagot tartalmazó antimikotikus kompozíció
Khan Effect of fluconazole on phagocytic response of polymorphonuclear leukocytes in a rat model of acute sepsis
KR20250102476A (ko) 산화 아연 및 아졸계 화합물의 병용 요법을 이용한 피부 감염증의 치료 방법
MXPA99002401A (en) Antifungal combination therapy
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
Calandra et al. Response to van Saene et al.'s comment on" Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients"
UCHIDA et al. Studies on the Antifungal Activities of 5-Flurocytosine 4. In Vitro and In Vivo Antitungal Activities against Dematiaceous Fungi
More et al. A REVIEW OF STUDY OF ANTIFUNGAL AGENTS
AU9530101A (en) Medicinal composition and in particular its use in fluid therapy